» Articles » PMID: 29576486

Characterization of Outcomes of 2-Stage Exchange Arthroplasty In the Treatment of Prosthetic Joint Infections

Overview
Journal J Arthroplasty
Specialty Orthopedics
Date 2018 Mar 27
PMID 29576486
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Two-stage revision is the preferred treatment for prosthetic hip and knee infections in the United States. Recent studies have questioned the true success rate of this treatment. The purpose of this study is to investigate outcomes of prosthetic hip and knee infections undergoing resection arthroplasty and spacer insertion at a single institution.

Methods: We identified 103 patients who underwent prosthesis resection and spacer placement for infection over a 10-year period. Twenty-three cases were excluded based on preset exclusion criteria leaving 80 cases (56 knees, 24 hips). A retrospective review was performed to examine the outcomes of these patients.

Results: Following spacer placement but before reimplantation, 9 (11.25%) of the 80 joints underwent repeat debridement and spacer exchange for persistent infection. Twenty-four (30.00%) patients had a serious complication during their treatment course. Fourteen (17.50%) patients never underwent reimplantation. Of these, 10 continued with spacer retention, 2 had resection arthroplasty, and 1 each had an amputation and an arthrodesis. Of the 66 patients with successful reimplantation, 48 (72.70%) remained infection free at most recent follow-up.

Conclusions: Two-stage revision does not result in the high rates of cure reported previously, when taking into account the substantial number of patients who never undergo the subsequent reimplantation surgery. Of those who underwent reimplantation in our study, many required additional spacer exchange or had complications. Surgeons and patients should consider these outcomes when discussing the treatment of prosthetic hip and knee infections.

Citing Articles

Risk factors of recurrent periprosthetic joint infection of the knee after two-stage reimplantation.

Lee D, Han H, Ro D Knee Surg Relat Res. 2025; 37(1):4.

PMID: 39810251 PMC: 11731532. DOI: 10.1186/s43019-025-00258-5.


How are Oral Antibiotics Being Used in Total Joint Arthroplasty? A Review of the Literature.

Weiner T, El-Najjar D, Herndon C, Wyles C, Cooper H Orthop Rev (Pavia). 2024; 16:92287.

PMID: 38283138 PMC: 10821814. DOI: 10.52965/001c.92287.


Orthopaedic infections: what have we learned?.

Lee C, Mayer E, Bernthal N, Wenke J, OToole R OTA Int. 2023; 6(2 Suppl):e250.

PMID: 37168032 PMC: 10166335. DOI: 10.1097/OI9.0000000000000250.


Neutralization of Staphylococcus aureus Protein A Prevents Exacerbated Osteoclast Activity and Bone Loss during Osteomyelitis.

Gehrke A, Mendoza-Bertelli A, Ledo C, Gonzalez C, Noto Llana M, Blanco C Antimicrob Agents Chemother. 2022; 67(1):e0114022.

PMID: 36533935 PMC: 9872667. DOI: 10.1128/aac.01140-22.


Short Course of Oral Antibiotic Treatment After Two-Stage Exchange Arthroplasty Appears to Decrease Early Reinfection.

Ryan S, Warne C, Osmon D, Tande A, Ledford C, Hyun M J Arthroplasty. 2022; 38(5):909-913.

PMID: 36496045 PMC: 10430476. DOI: 10.1016/j.arth.2022.12.006.